Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored, because the added beta-adrenergic blocking action of ZEBETA may produce excessive reduction of sympathetic activity.
<reserpine, effect, ZEBETA>, <guanethidine, effect, ZEBETA>